ANO1 and gastrointestinal stromal tumor: In the analysis of preoperative blood samples, 65 (54%) of 121 GIST patients were ANO1 positive, including 26 locally advanced GIST patients who received imatinib treatment before surgery (Figure 3A and 3B).